At the request of AlzeCure Pharma AB (publ), the last trading day in AlzeCure Pharma AB (publ)'s paid subscription units will be changed from May 30, 2024 to May 31, 2024. Short name: ALZCUR BTA ISIN code: SE0022060802 Orderbook ID: 334422 This information is distributed at the request of the Certified Adviser, FNCA Sweden AB. For further information, please call FNCA Sweden AB on +46(0)8-528 00 399.
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | AlzeCure Pharma: AlzeCure to Present at the Pharma Outsourcing Conference in Stockholm | STOCKHOLM, SWEDEN / ACCESSWIRE / November 27, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops small molecule drugs for... ► Artikel lesen | |
| 26.11. | AlzeCure Pharma to Present at Redeye Life Science Day on December 3 | STOCKHOLM, SWEDEN / ACCESSWIRE / November 26, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases... ► Artikel lesen | |
| 20.11. | AlzeCure Pharma to Present at Stora Aktiedagarna in Stockholm | STOCKHOLM, SWEDEN / ACCESSWIRE / November 20, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops candidate drugs for diseases... ► Artikel lesen | |
| 11.11. | AlzeCure Pharma: AlzeCure Publishes its Interim Report for January - September 2024 | STOCKHOLM, SE / ACCESSWIRE / November 11, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its interim report for the period January - September... ► Artikel lesen | |
| 30.10. | AlzeCure Pharma: AlzeCure Presents New Anti-Inflammatory Data with NeuroRestore ACD856 at the Alzheimer's Conference CTAD | STOCKHOLM, SE / ACCESSWIRE / October 30, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR), a pharmaceutical company that develops candidate drugs for diseases affecting... ► Artikel lesen |
